September 3, 2025 — Leads & Copy — ORLANDO, FLORIDA — Exousia Pro, Inc. (OTCPINK:MAJI) has filed with the State of Florida a new subsidiary to act as its operations holding company, Exousia Pro Holding Management, LLC (“EPHM”), for its three newly created divisions.
EPHM will own 100% of Exousia Ai, Inc., 100% of Exousia Health, Inc., and Exousia Wholesale, Inc. The company plans to file for two new patents during September 2025, one for Exousia Health and another for Exousia Wholesale. Further, it plans to file for several trademarks for products that it has developed. Exousia Health is expected to enter into a partnership that will provide it with access to approximately 200,000 active patients.
Matt Dwyer, President, stated that Exousia Pro has outlined a plan that allows each segment of the Company to flourish and, if warranted, be spun off and listed on a higher exchange. He added that the team has been working on new products that it can bring to market with low overhead, allowing it to generate revenue as it continues to build other segments of the Company.
Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter. The market for its new products is currently valued at $8.7 billion and is projected to grow to $18.5 billion over the next decade.
Exousia Pro (formerly Marijuana, Inc.) is a clinical-stage biotechnology company developing new ways to exploit the therapeutic potential of exosomes, initially focused on oncology.
Contact:
Investor Relations
ir@exousiapro.com
Source: Exousia Pro, Inc.
